The summary below is from the full report titled “Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer. A Randomized Trial.” It is in the 20 March 2007 issue of Annals of Internal Medicine (volume 146, pages 416-424). The authors are S.L. Greenspan, J.B. Nelson, D.L. Trump, and N.M. Resnick.
Preventing Bone Loss in Men with Prostate Cancer. Ann Intern Med. 2007;146:I–72. doi: https://doi.org/10.7326/0003-4819-146-6-200703200-00001
Download citation file:
Published: Ann Intern Med. 2007;146(6):I-72.
Endocrine and Metabolism, Hematology/Oncology, Metabolic Bone Disorders, Prostate Cancer.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use